4
Changes in Ownership
AbCellera Biologics Inc. Filed Acc 0001209191-22-062412
Chief Financial Officer acquired 50,000 shares (option exercise)
- Chief Financial Officer gave 50,000 shares (gift)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Booth Andrew Chief Financial Officer | 2022-12-20 | Option exercise | +50,000 | $0.19 | $9,500 | 188,500 | D |
| Booth Andrew Chief Financial Officer | 2022-12-20 | Gift | −50,000 | 138,500 | D | ||
| Derivatives | |||||||
| Booth Andrew Chief Financial Officer | 2022-12-20 | Option exercise · Share option (right to buy) | −50,000 | 5,820,481 | D | ||
Loading xslF345X03/doc4.xml…